Literature DB >> 35111470

Relapsing Extramedullary Multiple Myeloma Presenting As Acute Liver Failure.

Hafiza Wajeeha Javaid1, Farrukh Munir1, Saman Bahram2.   

Abstract

Extramedullary spread of multiple myeloma was thought to be uncommon but with recent advancements in imaging and increased patient survival, the incidence of the extraosseous disease has risen in living individuals. Despite this, the extraosseous spread of multiple myeloma has been under-diagnosed and under-reported. Timely diagnosis of this extraosseous disease is clinically important, as it indicates a more aggressive disease variant and carries a poor prognosis.
Copyright © 2021, Javaid et al.

Entities:  

Keywords:  acute liver failure; bilateral abducens nerve palsy; extramedullary multiple myeloma; extraosseous; multiple myeloma

Year:  2021        PMID: 35111470      PMCID: PMC8795222          DOI: 10.7759/cureus.20786

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  18 in total

1.  Ophthalmic manifestations of multiple myeloma.

Authors:  Shirley Fung; Dinesh Selva; Igal Leibovitch; James Hsuan; John Crompton
Journal:  Ophthalmologica       Date:  2005 Jan-Feb       Impact factor: 3.250

Review 2.  New Developments in Diagnosis, Prognosis, and Assessment of Response in Multiple Myeloma.

Authors:  Ola Landgren; S Vincent Rajkumar
Journal:  Clin Cancer Res       Date:  2016-11-15       Impact factor: 12.531

3.  Multiple myeloma with rupture of ovarian plasmacytoma.

Authors:  Yu-Ping Zhong; Jia-Jia Zhang; Xiao-Nan Huang
Journal:  Chin Med J (Engl)       Date:  2012-08       Impact factor: 2.628

Review 4.  Rapidly changing myeloma epidemiology in the general population: Increased incidence, older patients, and longer survival.

Authors:  Ingemar Turesson; Magnus Bjorkholm; Cecilie Hveding Blimark; Sigurdur Kristinsson; Ramon Velez; Ola Landgren
Journal:  Eur J Haematol       Date:  2018-04-20       Impact factor: 2.997

5.  Cranial nerve palsy in multiple myeloma and solitary plasmacytoma.

Authors:  Rajesh Kashyap; Raj Kumar; Shaleen Kumar
Journal:  Asia Pac J Clin Oncol       Date:  2010-11-03       Impact factor: 2.601

6.  Extramedullary vs medullary relapse after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) in multiple myeloma (MM) and its correlation to clinical outcome.

Authors:  R Zeiser; B Deschler; H Bertz; J Finke; M Engelhardt
Journal:  Bone Marrow Transplant       Date:  2004-12       Impact factor: 5.483

7.  Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study.

Authors:  Ola Landgren; Robert A Kyle; Ruth M Pfeiffer; Jerry A Katzmann; Neil E Caporaso; Richard B Hayes; Angela Dispenzieri; Shaji Kumar; Raynell J Clark; Dalsu Baris; Robert Hoover; S Vincent Rajkumar
Journal:  Blood       Date:  2009-01-29       Impact factor: 22.113

8.  MR imaging and PET/CT in diagnosis and management of multiple myeloma.

Authors:  Regan Ferraro; Ankit Agarwal; Erica L Martin-Macintosh; Patrick J Peller; Rathan M Subramaniam
Journal:  Radiographics       Date:  2015 Mar-Apr       Impact factor: 5.333

9.  Multiple myeloma: a clinicopathologic study of 62 consecutively autopsied cases.

Authors:  S B Kapadia
Journal:  Medicine (Baltimore)       Date:  1980-09       Impact factor: 1.889

Review 10.  Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations.

Authors:  Laura Rosiñol; Meral Beksac; Elena Zamagni; Niels W C J Van de Donk; Kenneth C Anderson; Ashraf Badros; Jo Caers; Michele Cavo; Meletios-Athanasios Dimopoulos; Angela Dispenzieri; Hermann Einsele; Monika Engelhardt; Carlos Fernández de Larrea; Gösta Gahrton; Francesca Gay; Roman Hájek; Vania Hungria; Artur Jurczyszyn; Nicolaus Kröger; Robert A Kyle; Fernando Leal da Costa; Xavier Leleu; Suzanne Lentzsch; Maria V Mateos; Giampaolo Merlini; Mohamad Mohty; Philippe Moreau; Leo Rasche; Donna Reece; Orhan Sezer; Pieter Sonneveld; Saad Z Usmani; Karin Vanderkerken; David H Vesole; Anders Waage; Sonja Zweegman; Paul G Richardson; Joan Bladé
Journal:  Br J Haematol       Date:  2021-03-16       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.